Business Outlook

For the second quarter of 2026, the Company expects total revenue growth in the mid-single digits.

For the full year 2026, Neuronetics continues to expect:

  • Total revenue between $160 million and $166 million;
  • Gross margin between 47% and 49%;
  • Operating expenses between $100 million and $105 million, inclusive of approximately $8.5 million of non-cash stock-based compensation;
  • Cash flow from operations between negative $13 million and negative $17 million;